4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001415889-24-018635
Director sold 10,000 shares at $3.99 ($39,900)
- Director acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Johnston John Joseph Director | 2024-06-27 | Option exercise 10b5-1 | +5,044 | $1.64 | $8,277 | 146,994 | D |
| Johnston John Joseph Director | 2024-06-27 | Option exercise 10b5-1 | +4,956 | $2.93 | $14,501 | 151,950 | D |
| Johnston John Joseph Director | 2024-06-27 | Sale 10b5-1 | −10,000 | $3.99 | $39,900 | 141,950 | D |
| Derivatives | |||||||
| Johnston John Joseph Director | 2024-06-27 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,044 | 1,121 | D | ||
| Johnston John Joseph Director | 2024-06-27 | Option exercise · Stock Option (right to buy) 10b5-1 | −4,956 | 13,396 | D | ||
| Open-market sales · 10,000 sh · avg $3.99 · $39,900 | |||||||
Loading xslF345X05/form4-07012024_090717.xml…